Forcefield Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.27M

  • Investors
  • 2

Forcefield Therapeutics General Information

Description

Provider of therapeutics intended to treat heart disease. The company offers treatments to protect heart function by preventing the loss of cardiomyocytes following myocardial infarction, enabling doctors to preserve patients' heart muscle during heart attacks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Victoria House, Bloomsbury Square
  • London WC1B 4DA
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Victoria House, Bloomsbury Square
  • London WC1B 4DA
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forcefield Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 28-Mar-2024 $1.27M Completed Generating Revenue
1. Early Stage VC 25-Apr-2022 Completed Generating Revenue
To view Forcefield Therapeutics’s complete valuation and funding history, request access »

Forcefield Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Preferred
Series A Preferred
To view Forcefield Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Forcefield Therapeutics Patents

Forcefield Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025253097-A1 Proteins with cardiopreservation activity Pending 03-Jun-2024

Forcefield Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Forcefield Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Roche Venture Fund Corporate Venture Capital Minority
Syncona Venture Capital Minority
To view Forcefield Therapeutics’s complete investors history, request access »

Forcefield Therapeutics FAQs

  • When was Forcefield Therapeutics founded?

    Forcefield Therapeutics was founded in 2020.

  • Where is Forcefield Therapeutics headquartered?

    Forcefield Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Forcefield Therapeutics?

    Forcefield Therapeutics has 8 total employees.

  • What industry is Forcefield Therapeutics in?

    Forcefield Therapeutics’s primary industry is Drug Discovery.

  • Is Forcefield Therapeutics a private or public company?

    Forcefield Therapeutics is a Private company.

  • What is the current valuation of Forcefield Therapeutics?

    The current valuation of Forcefield Therapeutics is .

  • What is Forcefield Therapeutics’s current revenue?

    The current revenue for Forcefield Therapeutics is .

  • How much funding has Forcefield Therapeutics raised over time?

    Forcefield Therapeutics has raised $8.45M.

  • Who are Forcefield Therapeutics’s investors?

    Roche Venture Fund and Syncona have invested in Forcefield Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process